- Home
- MLYS vs DGII Comparison
MLYS vs DGII Comparison
Compare MLYS & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- DGII
- Stock Information
- Founded
- MLYS 2019
- DGII 1985
- Country
- MLYS United States
- DGII United States
- Employees
- MLYS N/A
- DGII N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- DGII Computer peripheral equipment
- Sector
- MLYS Health Care
- DGII Technology
- Exchange
- MLYS Nasdaq
- DGII Nasdaq
- Market Cap
- MLYS 893.0M
- DGII 980.4M
- IPO Year
- MLYS 2023
- DGII N/A
- Fundamental
- Price
- MLYS $13.35
- DGII $26.30
- Analyst Decision
- MLYS Strong Buy
- DGII Buy
- Analyst Count
- MLYS 3
- DGII 5
- Target Price
- MLYS $33.00
- DGII $33.60
- AVG Volume (30 Days)
- MLYS 1.3M
- DGII 241.3K
- Earning Date
- MLYS 05-08-2025
- DGII 05-07-2025
- Dividend Yield
- MLYS N/A
- DGII N/A
- EPS Growth
- MLYS N/A
- DGII 119.70
- EPS
- MLYS N/A
- DGII 0.95
- Revenue
- MLYS N/A
- DGII $421,823,000.00
- Revenue This Year
- MLYS N/A
- DGII $2.08
- Revenue Next Year
- MLYS N/A
- DGII $4.37
- P/E Ratio
- MLYS N/A
- DGII $27.60
- Revenue Growth
- MLYS N/A
- DGII N/A
- 52 Week Low
- MLYS $8.24
- DGII $20.17
- 52 Week High
- MLYS $18.38
- DGII $37.07
- Technical
- Relative Strength Index (RSI)
- MLYS 49.65
- DGII 44.58
- Support Level
- MLYS $10.44
- DGII $24.43
- Resistance Level
- MLYS $14.83
- DGII $27.30
- Average True Range (ATR)
- MLYS 1.49
- DGII 1.69
- MACD
- MLYS -0.14
- DGII 0.19
- Stochastic Oscillator
- MLYS 43.24
- DGII 66.61
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.